Ibandronate and the risk of non-vertebral and clinical fractures in women with postmenopausal osteoporosis: results of a meta-analysis of phase III studies

By Harris Steven T.   Blumentals William A.   Miller Paul D.  

Current Medical Research and Opinion, Vol. 24, Iss. 1, 2008-01 ,pp. : 237-245

Informa Healthcare

Access to resources Recommend Favorite

Use of clinical risk factors to identify postmenopausal women with vertebral fractures

By Tobias J.   Hutchinson A.   Hunt L.   McCloskey E.   Stone M.   Martin J.   Thompson P.   Palferman T.   Bhalla A.  

Osteoporosis International, Vol. 18, Iss. 1, 2007-01 ,pp. : 35-43

Springer Publishing Company

Access to resources Recommend Favorite

Chondrosis of the disc – risk factor for osteoporotic vertebral fractures (biomechanical analysis)

By Wendlová Jaroslava  

Wiener Medizinische Wochenschrift, Vol. 160, Iss. 17-18, 2010-09 ,pp. : 464-469

Springer Publishing Company

Access to resources Recommend Favorite

The risk and burden of vertebral fractures in Sweden

By Kanis J.   Johnell O.   Oden A.   Borgstrom F.   Zethraeus N.   Laet C.   Jonsson B.  

Osteoporosis International, Vol. 15, Iss. 1, 2004-01 ,pp. : 20-26

Springer Publishing Company

Access to resources Recommend Favorite

Year-by-year analysis of cardiovascular events in the Multiple Outcomes of Raloxifene Evaluation (MORE) trial

By Keech Cheryl A.   Sashegyi Andreas   Barrett-Connor Elizabeth  

Current Medical Research and Opinion, Vol. 21, Iss. 1, 2005-01 ,pp. : 135-140

Informa Healthcare

Access to resources Recommend Favorite